Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis.

Infection and Immunity
P M SullamA L Cheung

Abstract

The direct binding of platelets by bacteria is a postulated central mechanism in the pathogenesis of endocarditis. To address the role of binding more definitively, we employed Tn551 insertional mutagenesis of Staphylococcus aureus parental strain ISP479 to generate an isogenic variant (strain PS12) that bound platelets minimally. As compared with the binding of ISP479, the binding of PS12 to platelet monolayers was reduced by 67.2%. Similarly, the binding of PS12 to platelets in suspension was reduced by 71.3%, as measured by flow cytometry. The low-binding phenotype was transducible into both ISP479 and S. aureus Newman. Southern blotting indicated that a single copy of Tn551 was inserted within the chromosomes of PS12 and the transductants. When tested in a rabbit model, animals inoculated with PS12 were significantly less likely to develop endocarditis and had lower densities of organisms (CFU per gram) within vegetations and a decreased incidence of renal abscess formation, as compared with animals inoculated with the parental strain. The diminished virulence of PS12 was not attributable to a reduction in the initial attachment of organisms to the damaged endocardium, since 30 min after inoculation, PS12-infected animals h...Continue Reading

References

Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R P NovickP A Pattee
Jul 1, 1992·The Journal of Infectious Diseases·M R YeamanA S Bayer
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A L CheungV A Fischetti
Jan 1, 1991·Methods in Enzymology·R P Novick
Nov 1, 1990·Infection and Immunity·P M SullamF H Valone
Aug 1, 1987·Infection and Immunity·P M SullamJ Mills
Nov 1, 1986·Veterinary Pathology·C M JohnsonD N Fass
Apr 1, 1983·Journal of Bacteriology·B Berger-Bächi
Nov 1, 1994·The Journal of Clinical Investigation·A L CheungA S Bayer
Jul 1, 1994·Antimicrobial Agents and Chemotherapy·M R YeamanA S Bayer
Oct 1, 1993·The Journal of Infectious Diseases·P M SullamH F Chambers
Jan 1, 1996·Journal of Bacteriology·J H HeinrichsA L Cheung
Aug 1, 1996·Journal of Bacteriology·M G BayerA L Cheung

❮ Previous
Next ❯

Citations

Nov 30, 2000·Current Infectious Disease Reports·M R Yeaman, A S Bayer
Oct 24, 2002·Blood·Ulf SjöbringZaverio M Ruggeri
Jul 17, 2003·The Journal of Clinical Investigation·Mathias Herrmann
Mar 26, 2004·Nature Reviews. Microbiology·Luanne Hall-StoodleyPaul Stoodley
Apr 2, 2005·British Journal of Haematology·Christopher PlummerC W Ian Douglas
Jan 6, 2007·Circulation Research·Philipp von Hundelshausen, Christian Weber
Jan 17, 2008·Annals of Biomedical Engineering·Michael A Johnson, Julia M Ross
Feb 19, 2009·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·François RouzetDominique Le Guludec
Mar 26, 2015·Platelets·Archie McNicol
Apr 23, 2004·Infection and Immunity·Jean-San ChiaJen-Yang Chen
Apr 9, 2001·Infection and Immunity·I R SibooP M Sullam
May 20, 2006·Nature Reviews. Microbiology·J Ross FitzgeraldDermot Cox
Oct 7, 2003·Annual Review of Microbiology·Matthew R Parsek, Pradeep K Singh
Dec 8, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Steven W KerriganDermot Cox
Jul 23, 2011·Journal of Medical Microbiology·Nattakan LakkitjaroenTsutomu Sekizaki
Mar 15, 2015·Frontiers in Immunology·Hind Hamzeh-CognasseOlivier Garraud
Apr 16, 1998·Molecular Microbiology·A M LoweR L Deresiewicz
May 13, 2003·Biotechnology and Bioengineering·Lisa MascariJulia M Ross
Jul 11, 2006·Current Infectious Disease Reports·Eleonora WidmerPhilippe Moreillon
Sep 8, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Ammar HabibUNKNOWN Mayo Cardiovascular Infections Study Group
Jan 22, 2010·Cellular and Molecular Life Sciences : CMLS·Steven W Kerrigan, Dermot Cox
Aug 30, 2012·Proteomics·Mark J J B SibbaldJan Maarten van Dijl
Nov 14, 2014·Genome Medicine·Frank HansesJean C Lee
Sep 19, 2014·Current Infectious Disease Reports·Emanuele Durante-MangoniDomenico Iossa
Feb 17, 2001·Infection and Immunity·B A BensingP M Sullam

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.